Evoke Neuroscience - About the company
Evoke Neuroscience is an acquired company based in New York City (United States), founded in 2009 by and . It operates as a Developer of memory loss biomarkers to treat cognitive disorders. The company has 206 active competitors, including 70 funded and 17 that have exited. Its top competitors include companies like Ceribell, Neuralink and Cumulus Neuroscience.
Company Details
Developer of memory loss biomarkers to treat cognitive disorders. They have developed a system that enables physicians to diagnose and manage memory loss, cognitive impairment, and other stress-related conditions. The system works by biomarking of physiological aging and memory performance. This can allow for early detection of memory loss and MCI It shows the electrical activity of a patient’s brain using electroencephalograph (EEG) and event-related potentials (ERP).
- Website
- Social
- Email ID
- @evokeneuroscience.com, @evokeneuroscience.com
- Phone Number
- +1
- Registered Address
- New York, New York
Key Metrics
Founded Year
2009
Location
New York City, United States
Stage
Acquired
Investors
Ranked
23rd among
Employee Count
as on Dec 31, 2021
Similar Companies
Ceribell &
Exit Details
Acquired by FireFly Neuroscience (May 06, 2025)
Legal entities associated with Evoke Neuroscience
Evoke Neuroscience is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
---|---|---|---|---|
CIN: 271554133 United States, Active | Dec 26, 999 | - | 12 (as on Dec 31, 2021) | - |
Evoke Neuroscience's acquisition details
Evoke Neuroscience got acquired by FireFly Neuroscience on May 06, 2025 at an acquisition amount of $6M.
Click to take a look at Evoke Neuroscience's acquisition in detail
Evoke Neuroscience's funding and investors
Evoke Neuroscience is a funded company.
Evoke Neuroscience has 1 institutional investor - .
View details of Evoke Neuroscience's funding rounds and investors
Evoke Neuroscience's founders and board of directors
The founders of Evoke Neuroscience are and .
Here are the details of Evoke Neuroscience's key team members:
- : Co-Founder of Evoke Neuroscience.
- : Co-Founder & CTO of Evoke Neuroscience. Contact Info:
View details of
Evoke Neuroscience's employee count trend
Evoke Neuroscience has 12 employees as of Dec 21. The total employee count is 9.0% more than what it was in Dec 20. Here is Evoke Neuroscience's employee count trend over the years:Access ÃØÃÜÑо¿Ëù on any website
Our Google Chrome extension lets you view company details while browsing their websites
Evoke Neuroscience's Competitors and alternates
Top competitors of Evoke Neuroscience include Ceribell, Neuralink and Cumulus Neuroscience. Here is the list of Top 10 competitors of Evoke Neuroscience, ranked by ÃØÃÜÑо¿Ëù score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | ![]() Ceribell 2014, Mountain View (United States), Public | EEG system for the diagnosis of seizures | $188M | Longitude Capital, RA Capital ManagementÌý&²¹³¾±è;Ìý | 65/100 |
2nd | Neuralink 2016, San Francisco (United States), Series E | Provider of implantable brain-computer interfaces | $1.29B | Sequoia Capital, Google VenturesÌý&²¹³¾±è;Ìý | 59/100 |
3rd | ![]() Cumulus Neuroscience 2015, Belfast (United Kingdom), Series A | AI and cloud-based brain physiology analysis tool for clinical trials | $15.2M | SV Health Investors, British Business InvestmentsÌý&²¹³¾±è;Ìý | 59/100 |
4th | Emotiv 2011, San Francisco (United States), Seed | Manufacturer of wireless EEG headsets and software solutions | $7.41M | Cicada Innovations, TechstarsÌý&²¹³¾±è;Ìý | 55/100 |
5th | ![]() Openwater 2016, San Francisco (United States), Series C | Provider of imaging technologies for medical diagnosis and treatments | $100M | Excel Venture Management, Lauder PartnersÌý&²¹³¾±è;Ìý | 55/100 |
6th | ![]() BrainScope 2006, Bethesda (United States), Series B | Developer of non-invasive point-of-care diagnostic device for EEG recording and diagnosing traumatic brain injury | $62.2M | , Ìý&²¹³¾±è;Ìý | 53/100 |
7th | ![]() Kernel 2016, Los Angeles (United States), Series C | Developer of multimodal brain measurement technology for neuromedicine | $158M | Khosla Ventures, General CatalystÌý&²¹³¾±è;Ìý | 52/100 |
8th | Mynd Analytics 1999, Aliso Viejo (United States), Public | Provider of reference data and analytic tools for clinicians and researchers in psychiatry. | - | SAIL Capital Partners, Aspire CapitalÌý&²¹³¾±è;Ìý | 52/100 |
9th | Cercare Medical 2013, Aarhus (Denmark), Series A | Provider of diagnostic software for acute stroke management | $7.82M | West Hill Capital, Ìý&²¹³¾±è;Ìý | 52/100 |
10th | Beacon Biosignals 2019, Boston (United States), Series A | AI-based EEG analysis and diagnosis platform for healthcare providers | $30M | Casdin Capital, General CatalystÌý&²¹³¾±è;Ìý | 51/100 |
23rd | 2009, New York City (United States), Acquired | Developer of memory loss biomarkers to treat cognitive disorders | - | 41/100 |
Looking for more details on Evoke Neuroscience's competitors? Click to see the top ones
Evoke Neuroscience's Investments and acquisitions
Evoke Neuroscience has made no investments or acquisitions yet.
Reports related to Evoke Neuroscience
Here is the latest report on Evoke Neuroscience's sector:
View
News related to Evoke Neuroscience
Media has covered Evoke Neuroscience for 1 event in last 1 year.
•
•
Are you a Founder ?
FAQ's about Evoke Neuroscience
Explore our recently published companies
- Future Monk Invetments - Unfunded company
- TOMPLA - Kawasaki based, 2021 founded, Funding Raised company
- Help On Assignment - New York City based, 2024 founded, Unfunded company